June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) clinical program evaluating the novel Shockwave SkyRunner Carotid Intravascular ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
June 25, 2026 — Johnson & Johnson has announced the initiation of its Skyward investigational device exemption (IDE) ...
June 23, 2026 — The European Society of Cardiology (ESC) Congress 2026 will take place in Munich Aug. 28–31, 2026. ESC ...
June 17, 2026 — VahatiCor, Inc., a medtech company developing interventional therapies for coronary microvascular ...
June 13, 2026 — New research shows that infrainguinal endovascular interventions for peripheral artery disease (PAD) ...
June 9 2026 — With the project “Triaging artificial intelligence (AI) Tool For Pulmonary Health Using Spectral X-ray ...
May 20, 2026 — Medtronic has released the three-year results of the SMall Annuli Randomized To Evolut or SAPIEN (SMART) ...
May 10, 2026 — WhiteSwell has announced primary results from the DELTA-HF feasibility clinical trial evaluating the eLym ...
May 10, 2026 — Results from the first randomized trial evaluating microRNA inhibition in heart failure were presented ...
May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...
May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...
June 25, 2026